Baseline characteristics.
chronic kidney disease, spasticity, shock, HTN, stroke, Diabetes Mellitus, atrial fibrillation, hypertension, dyslipidemia
ISCHEMIC HEART DISEASE, SHOCK, STROKE, DIABETES MELLITUS, RECRUITMENT, HTN, IHD, ATRIAL FIBRILLATION, HYPERTENSION, DYSLIPIDEMIA
rESWT-radial Extracorporeal shock wave therapy, TENS-Transcutaneous electrical nerve stimulation, 1-rESWT, 2-TENS, MAS-Modified Ashworth Scale, VCG-voluntary control grading, FMA-UL-Fugl Mayer assessment of upper limb, ARAT-Action research arm test, IS-Ischemic stroke, HS-Hemorrhagic stroke, M-Male, F-Female, Rt-Right, Lt-Left, SD-standard deviationSixty-four out of 106 subjects (60.4%) reported having medical co-morbidities. Among those 64 (100% co-morbidities) the following conditions were testified as having alone or as a combination; 53 had hypertension (HTN-82.81%), 40 had Diabetes Mellitus (DM-62.5%), 12 had ischemic heart disease (IHD-18.75%), three had chronic kidney disease (CKD-4.68%), one had atrial fibrillation (AF-1.56%), and one had dyslipidemia (DLP-1.56%) previously diagnosed. Among those 64 subjects, 16 were presented with HTN alone (25%), 11 with HTN and DM (17.18%), 10 with HTN, DM and, DLP (15.62%), seven with DM alone (10.93%) and, five subjects presented with HTN, DM, and IHD (7.81%) combinations. These included patients who were taking medications only for their present co-morbidities. They were not under any medications to treat spasticity at the stage of patient recruitment and they didn’t take any anti-spastic drugs throughout the treatment protocol. They were only treated with either rESWT or TENS for spasticity management.